June 9, 2023 News by Mary Chapman National MS Society, MS Canada tops in peer-to-peer fundraising The National Multiple Sclerosis Society (NMSS) has earned a shoutout from the digital fundraising platform DonorDrive for being recognized as one of the top 30 peer-to-peer fundraising programs in the U.S. by the Peer-to-Peer Professional Forum. MS Canada also made the list for the top…
May 30, 2023 News by Lindsey Shapiro, PhD Clene wins grant to develop CNM-Au8 for progressive MS The National Multiple Sclerosis Society has awarded Clene Nanomedicine a grant to advance its treatment candidate CNM-Au8 for people with nonactive, progressive forms of multiple sclerosis (MS). The funding comes from the MS Society’s Fast Forward Program, which supports commercial organizations developing promising new MS therapies,…
June 16, 2022 News by Steve Bryson, PhD Signal Detection Theory May Help Measure MS Cognitive Fatigue A new tool called signal detection theory (SDT) found a relationship between subjective cognitive fatigue, often experienced by people with multiple sclerosis (MS), and the activation of certain brain regions, a study reported. Although the relationship was found in both patients and healthy controls after cognitive fatigue was…
March 25, 2022 News by Margarida Maia, PhD MS Research Prize Goes to Barcelona Neurologist A researcher in Barcelona, Spain, has been chosen to receive the 2022 John Dystel Prize for his work advancing the understanding, diagnosis, and treatment of multiple sclerosis (MS). The $40,000 prize, given jointly by the National MS Society and the American Academy of Neurology (AAN), will be…
March 24, 2022 News by Lindsey Shapiro, PhD Online Mindfulness Program Helps Patients With Depression, Trial Finds Eight weeks of an online mindfulness program significantly lowered levels of depression and improved quality of life in people with multiple sclerosis (MS), researchers in Australia report. āThis study adds to growing evidence on how wellness strategies can help people with MS to reduce symptoms and enable fuller participation…
March 17, 2022 News by Steve Bryson, PhD MS Focus of Paralyzed Veterans of America’s Newest Committee Paralyzed Veterans of America (PVA) has formed a committee to better address the needs and interests of veterans with multiple sclerosis (MS), including help with obtaining care and disability benefits. The nonprofit PVA is the only congressionally chartered veterans organization working to assist and represent veterans with spinal…
March 8, 2022 News by Lindsey Shapiro, PhD MS Society, Corporate Partners Commit to Diversity in Clinical Trials The National MS Society, together with a number of its corporate healthcare partners, want to help correct the lack of diversity in clinical trials as part of an effort toward resolving healthcare inequities in the MS community. To address these disparities, the National MS Societyās Corporate Healthcare Roundtable, a…
February 17, 2022 News by Patricia Inacio, PhD UPenn Neurologist Wins Barancik Prize for Innovation in MS Research A neurology professor at the University of Pennsylvania (UPenn) has received the 2021 Barancik Prize for Innovation in MS Research for his work in understanding how the immune system causes multiple sclerosis (MS). The international $100,000 prize, administered by the National MS Society, was awarded to Amit…
February 4, 2022 News by Margarida Maia, PhD Researcher Will Use Award to Find Biomarkers of RIS in Children This yearās Harry Weaver Neuroscience Scholar Award, funded by the National Multiple Sclerosis (MS) Society, has gone to a Yale University researcher who is searching for biomarkers of radiologically isolated syndrome (RIS) in children. RIS occurs when imaging findings on MRI scans are similar to those seen in people…
January 18, 2022 News by Hawken Miller Tyler Campbell Traded Football Cleats for a Microphone It took some time for Tyler Campbell to truly accept he had relapsing-remitting multiple sclerosis. The San Diego State University running back had just finished his junior year in 2007 when his multiple sclerosis (MS) symptoms began. After an MRI confirmed the diagnosis, his neurologist cleared him to…
January 4, 2022 News by Patricia Inacio, PhD Minorities, Others With Depression, Asked to Join Support Group Study Adults with multiple sclerosis (MS) and depression or anxiety, especially those of minority groups, are being asked to join a clinical trial assessing the benefits of eSupport Health’s online support group program, the National MS Society announced in aĀ press release. The CONNECT study is particularly focused on Black and…
December 10, 2021 News by Marisa Wexler, MS National MS Society Funds 13 New Research Projects The National MS Society has announced it is funding 13 new research projects that seek to better understand the risk factors involved in multiple sclerosis (MS) development and progression. The funding ā nearly $7 million in total ā also will go to “rescue” 22 MS-related research projects that…
November 29, 2021 Columns by Ed Tobias MS News That Caught My Eye Last Week: Stem Cell Trial, COVID-19 Vaccines, MS Blood Test First Patient Dosed in Phase 1 Trial of IMS001 Therapy IMS001 is an investigational treatment that uses mesenchymal stem cells (MSC) ā cells derived from human embryos. Preclinical studies have shown that IMS001 has the ability to stabilize an overactive immune system, as is the case in people with…
November 22, 2021 News by Margarida Maia, PhD COVID-19 Vaccine Side Effects With MS Similar to Public at Large Side effects upon receiving the COVID-19 vaccine in people withĀ multiple sclerosis (MS) are similar to those reported in the general population, and patients on certain disease-modifying therapies are less likely to have vaccine reactions,Ā a survey-based study found. The findings provide āa reassuring pictureā for those who feel hesitant about…
October 18, 2021 News by Marisa Wexler, MS #ECTRIMS2021 ā Economic Burden of MS in US Exceeded $85B in 2019 Editorās note: TheĀ Multiple Sclerosis News Today team is providing in-depth coverage of the virtual 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Oct. 13ā15. GoĀ here to see the latest stories from the conference. The total economic…
September 24, 2021 News by Somi Igbene, PhD Mount Sinai MS Experts Earn Hope Award The National Multiple Sclerosis Society has granted its 2021 Hope Award to two multiple sclerosis (MS) experts at Mount Sinai Health System for their clinical ingenuity and significant research contributions that have uplifted individuals, families and communities affected with the chronic condition. Aaron Miller, MD, professor of neurology…
August 25, 2021 News by Teresa Carvalho, MS DC United Goals Now Worth Up to $20,000 for National MS Society D.C. UnitedĀ andĀ its official sponsor, Leidos, opened a campaign to donate up to $20,000 to the National Multiple Sclerosis (MS) Society, the soccer team announced. The initiative aims to support the almost one million people in the U.S. living with multiple sclerosis (MS). Among them is…
August 24, 2021 News by Margarida Maia, PhD MS Society to Hold Black MS Experience Summit The National Multiple Sclerosis Society will host the second edition of its Black MS Experience Summit, a virtual event to help forge connections among those who understand the experience of living with multiple sclerosis (MS) as a Black person. Register hereĀ to join the interactive, two-day…
August 23, 2021 News by Marisa Wexler, MS Variant in STK11 Gene Tied to Greater MS Risk for Black People in US A variation in a gene calledĀ STK11, previously shown to increase the risk for multiple sclerosis (MS) among Caucasians, is now also linked to a greater likelihood of MS in Black people. In fact, the variation was significantly more common in Black MS patients with secondary progressive MS (SPMS),…
August 18, 2021 News by Marisa Wexler, MS Trial Will Test Ocrevus on Arm, Hand Function in PPMS A Phase 3 clinical trial testing the effect of Ocrevus (ocrelizumab) on upper limb disability progression in people with primary progressive multiple sclerosis (PPMS) is recruiting participants. The trial, called O’HAND (NCT04035005), expects to enroll approximately 1,000 adults with PPMS, ages 18 to 65, at more than…
June 17, 2021 News by Mary Chapman $1M Gift Will Expand Adventure-based Healing Program A $1 million gift from Velocity Global will help expand First Descents, an adventure program for young adults living with multiple sclerosis (MS) or other serious chronic conditions. The money will go toward program development and is expected to help First Descents reach 1,000 MS patients over…
May 21, 2021 News by Steve Bryson, PhD MedRhythms Launches Trial of Rhythmic Sound Therapy to Aid Walking The digital therapeutics company MedRhythmsĀ is launching a clinical trial to evaluate the safety and efficacy of MR-004, an experimental product that uses rhythmic sounds to improve walking abilities in people with multiple sclerosis (MS). The randomized…
April 15, 2021 News by Steve Bryson, PhD Harvard Professor Wins Dystel Prize for Uncovering MS Immune Mechanisms The 2021 John Dystel Prize for multiple sclerosis (MS) research has been awarded to Vijay Kuchroo, PhD, a professor at Harvard Medical School, in Boston, for his work in uncovering the underlying immune mechanisms that drive the neurodegenerative disorder.Ā āProfessor Kuchrooās…
March 26, 2021 News by Vanda Pinto, PhD NurOwn Cell Therapy Found Safe, Effective for Progressive MS in Phase 2 Trial NurOwn cell therapy led to significant improvements in the physical abilities, vision, and cognition of people withĀ progressive multiple sclerosis (MS) in a Phase 2 clinical trial, top-line data show. In addition to these positive efficacy results, BrainStorm Cell Therapeutics, NurOwn’s developer, announced that its cell-based therapy showed…
March 22, 2021 News by Margarida Maia, PhD National MS Society Encourages Patients to Get COVID-19 Vaccine Most patients with relapsing and progressive forms of multiple sclerosis (MS) are encouraged to get vaccinated against COVID-19 ā and any vaccine of three authorized for use in the U.S. is safe to receive ā according to recent guidance from the National MS Society. Despite mounting evidence that…
March 5, 2021 News by Mary Chapman It’s March – Make Time for MS Awareness Note: This story was updated March 8, 2021, to note that tickets for MSAA’s Virtual Art Tour are still available for purchase.Ā Activities are underway to mark Multiple Sclerosis Awareness Month, set aside each year to call attention to the neurodegenerative disorder estimated to affect almostĀ 1 million U.S.
March 4, 2021 News by Teresa Carvalho, MS BMS Grants to National MS Society, Others Aim for Diversity in Care and Trials The National Multiple Sclerosis SocietyĀ was among 56 nonprofit organizations chosen byĀ Bristol Myers SquibbĀ to share an $11 million award supporting projects that promote health equity and access to better care across ethnically and racially diverse and underserved communities in the U.S. Other awarded projects aim to promote diversity…
March 3, 2021 News by Marta Figueiredo, PhD NMSS Partnership Targets Autoimmune Disease Research The National Multiple Sclerosis Society has joined forces with the diabetes-focused JDRF and the Lupus Research Alliance to fund research looking at common underlying mechanisms of autoimmune disease. Called “Decoding Immune-Mediated Diseases ā Novel Approaches for Therapeutic Insights,” the new joint grant program is meant to stimulate…
February 23, 2021 News by Diana Campelo Delgado Johns Hopkins Neuroscientist Wins 2020 Barancik Prize for Innovation The 2020 Barancik Prize for Innovation in MS Research has been awarded to neuroscientistĀ Dwight E. Bergles, PhD, a Johns Hopkins University professor,Ā for his work in understanding the function of brain cells in multiple sclerosis (MS). This international prize awards $100,000 to the recipient. Administered by the National MS…
February 12, 2021 News by Marta Figueiredo, PhD National MS Society Urges DMT Dosing Changes for COVID-19 Vaccinations To potentially increase the effectiveness of COVID-19 vaccines in people with multiple sclerosis (MS), the National Multiple Sclerosis Society is recommending dosing adaptations for some disease-modifying therapies (DMTs). Based on expert consensus and available data, the guidance is particularly relevant for MS patients considering initiating or already being…